Science 3 April 1992: Vol. 256. no. 5053, pp. 102 - 105 DOI: 10.1126/science.1566048

Prev | Table of Contents | Next

Articles

Analysis of Fecal DNA Methylation to Detect Gastrointestinal Neoplasia.

T. Nagasaka, N. Tanaka, H. M. Cullings, D.-S. Sun, H. Sasamoto, T. Uchida, M. Koi, N. Nishida, Y. Naomoto, C. R. Boland, et al. (2009)
J Natl Cancer Inst 101, 1244-1258
 |  Abstract »  |  Full Text »  |  PDF »

Fecal Cyclooxygenase 2 Plus Matrix Metalloproteinase 7 mRNA Assays as a Marker for Colorectal Cancer Screening.

T. Takai, S. Kanaoka, K.-i. Yoshida, Y. Hamaya, M. Ikuma, N. Miura, H. Sugimura, M. Kajimura, and A. Hishida (2009)
Cancer Epidemiol. Biomarkers Prev. 18, 1888-1893
 |  Abstract »  |  Full Text »  |  PDF »

3,3'-Diindolylmethane Enhances the Efficacy of Butyrate in Colon Cancer Prevention through Down-Regulation of Survivin.

N. Bhatnagar, X. Li, Y. Chen, X. Zhou, S. H. Garrett, and B. Guo (2009)
Cancer Prevention Research 2, 581-589
 |  Abstract »  |  Full Text »  |  PDF »

KRAS Mutations and Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer: Practical Application of Patient Selection.

A. Jimeno, W. A. Messersmith, F. R. Hirsch, W. A. Franklin, and S. G. Eckhardt (2009)
J. Clin. Oncol. 27, 1130-1136
 |  Abstract »  |  Full Text »  |  PDF »

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers.

C. M. Sturgeon, M. J. Duffy, U.-H. Stenman, H. Lilja, N. Brunner, D. W. Chan, R. Babaian, R. C. Bast Jr., B. Dowell, F. J. Esteva, et al. (2008)
Clin. Chem. 54, e11-e79
 |  Abstract »  |  Full Text »  |  PDF »

Stool DNA Testing and Colon Cancer Prevention: Another Step Forward.

D. C. Chung (2008)
Ann Intern Med 149, 509-510
 |  Full Text »  |  PDF »

Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

B. Levin, D. A. Lieberman, B. McFarland, R. A. Smith, D. Brooks, K. S. Andrews, C. Dash, F. M. Giardiello, S. Glick, T. R. Levin, et al. (2008)
CA Cancer J Clin 58, 130-160
 |  Abstract »  |  Full Text »  |  PDF »

The Biological Revolution: Understanding the Impact of SNPs on Diet-Cancer Interrelationships.

J. C. Mathers and J. E. Hesketh (2007)
J. Nutr. 137, 253S-258S
 |  Abstract »  |  Full Text »  |  PDF »

Molecular Screening Testing for Colorectal Cancer.

B. Levin (2006)
Clin. Cancer Res. 12, 5014-5017
 |  Full Text »  |  PDF »

A sensitive method to quantify human long DNA in stool: relevance to colorectal cancer screening..

H. Zou, J. J. Harrington, K. K. Klatt, and D. A. Ahlquist (2006)
Cancer Epidemiol. Biomarkers Prev. 15, 1115-1119
 |  Abstract »  |  Full Text »  |  PDF »

Detection and quantification of mutations in the plasma of patients with colorectal tumors.

F. Diehl, M. Li, D. Dressman, Y. He, D. Shen, S. Szabo, L. A. Diaz Jr, S. N. Goodman, K. A. David, H. Juhl, et al. (2005)
PNAS 102, 16368-16373
 |  Abstract »  |  Full Text »  |  PDF »

Detection in Fecal DNA of Colon Cancer-Specific Methylation of the Nonexpressed Vimentin Gene.

W.-D. Chen, Z. J. Han, J. Skoletsky, J. Olson, J. Sah, L. Myeroff, P. Platzer, S. Lu, D. Dawson, J. Willis, et al. (2005)
J Natl Cancer Inst 97, 1124-1132
 |  Abstract »  |  Full Text »  |  PDF »

Narrative Review: Screening for Colorectal Cancer in Patients with a First-Degree Relative with Colonic Neoplasia.

G. M. Eisen and D. S. Weinberg (2005)
Ann Intern Med 143, 190-198
 |  Abstract »  |  Full Text »  |  PDF »

Fecal DNA versus Fecal Occult Blood for Colorectal-Cancer Screening in an Average-Risk Population.

T. F. Imperiale, D. F. Ransohoff, S. H. Itzkowitz, B. A. Turnbull, M. E. Ross, and the Colorectal Cancer Study Group (2004)
N. Engl. J. Med. 351, 2704-2714
 |  Abstract »  |  Full Text »  |  PDF »

Hybridization Isotherms of DNA Microarrays and the Quantification of Mutation Studies.

A. Halperin, A. Buhot, and E. B. Zhulina (2004)
Clin. Chem. 50, 2254-2262
 |  Abstract »  |  Full Text »  |  PDF »

Enhanced Retrieval of DNA from Human Fecal Samples Results in Improved Performance of Colorectal Cancer Screening Test.

D. Whitney, J. Skoletsky, K. Moore, K. Boynton, L. Kann, R. Brand, S. Syngal, M. Lawson, and A. Shuber (2004)
J. Mol. Diagn. 6, 386-395
 |  Abstract »  |  Full Text »  |  PDF »

Chemoprevention of Cancer.

A. S. Tsao, E. S. Kim, and W. K. Hong (2004)
CA Cancer J Clin 54, 150-180
 |  Abstract »  |  Full Text »  |  PDF »

Real-Time Gap Ligase Chain Reaction: A Rapid Semiquantitative Assay for Detecting p53 Mutation at Low Levels in Surgical Margins and Lymph Nodes from Resected Lung and Head and Neck Tumors.

S. V. Harden, D. C. Thomas, N. Benoit, K. Minhas, W. H. Westra, J. A. Califano, W. Koch, and D. Sidransky (2004)
Clin. Cancer Res. 10, 2379-2385
 |  Abstract »  |  Full Text »  |  PDF »

DNA Enrichment by Allele-Specific Hybridization (DEASH): A Novel Method for Haplotyping and for Detecting Low-Frequency Base Substitutional Variants and Recombinant DNA Molecules.

A. J. Jeffreys and C. A. May (2003)
Genome Res. 13, 2316-2324
 |  Abstract »  |  Full Text »  |  PDF »

Microsatellite Changes in Nipple Aspirate Fluid and Breast Tissue from Women with Breast Carcinoma or Its Precursors.

W. Zhu, W. Qin, H. Ehya, J. Lininger, and E. Sauter (2003)
Clin. Cancer Res. 9, 3029-3033
 |  Abstract »  |  Full Text »  |  PDF »

DNA Integrity as a Potential Marker for Stool-based Detection of Colorectal Cancer.

K. A. Boynton, I. C. Summerhayes, D. A. Ahlquist, and A. P. Shuber (2003)
Clin. Chem. 49, 1058-1065
 |  Abstract »  |  Full Text »  |  PDF »

Quantification of Human DNA in Feces as a Diagnostic Test for the Presence of Colorectal Cancer.

C. H.W. Klaassen, M. A.F. Jeunink, C. F.M. Prinsen, T. J.M. Ruers, A. C.I.T.L. Tan, L. J.A. Strobbe, and F. B.J.M. Thunnissen (2003)
Clin. Chem. 49, 1185-1187
 |  Full Text »  |  PDF »

A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.

B M Ryan, F Lefort, R McManus, J Daly, P W N Keeling, D G Weir, and D Kelleher (2003)
Mol. Pathol. 56, 172-179
 |  Abstract »  |  Full Text »  |  PDF »

Colorectal Cancer Screening: Scientific Review.

J. M. E. Walsh and J. P. Terdiman (2003)
JAMA 289, 1288-1296
 |  Abstract »  |  Full Text »  |  PDF »

Tumor Location and Detection of K-Ras Mutations in Stool From Colorectal Cancer Patients.

M. Frattini, D. Balestra, S. Pilotti, L. Bertario, and M. A. Pierotti (2003)
J Natl Cancer Inst 95, 72-73
 |  Full Text »  |  PDF »

A rat virus visits the clinic: translating basic discoveries into clinical medicine in the 21st century.

C R Boland and A Goel (2003)
Gut 52, 8-9
 |  Full Text »  |  PDF »

A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.

B M Ryan, F Lefort, R McManus, J Daly, P W N Keeling, D G Weir, and D Kelleher (2003)
Gut 52, 101-108
 |  Abstract »  |  Full Text »  |  PDF »

Tumor DNA in Plasma at Diagnosis of Breast Cancer Patients Is a Valuable Predictor of Disease-free Survival.

J. M. Silva, J. Silva, A. Sanchez, J. M. Garcia, G. Dominguez, M. Provencio, L. Sanfrutos, E. Jareno, A. Colas, P. Espana, et al. (2002)
Clin. Cancer Res. 8, 3761-3766
 |  Abstract »  |  Full Text »  |  PDF »

Diagnostic Biochip Array for Fast and Sensitive Detection of K-ras Mutations in Stool.

L. Prix, P. Uciechowski, B. Bockmann, M. Giesing, and A. J. Schuetz (2002)
Clin. Chem. 48, 428-435
 |  Abstract »  |  Full Text »  |  PDF »

Detection of APC Mutations in Fecal DNA from Patients with Colorectal Tumors.

G. Traverso, A. Shuber, B. Levin, C. Johnson, L. Olsson, D. J. Schoetz Jr., S. R. Hamilton, K. Boynton, K. W. Kinzler, and B. Vogelstein (2002)
N. Engl. J. Med. 346, 311-320
 |  Abstract »  |  Full Text »  |  PDF »

Detection of Helicobacter pylori in faeces by culture, PCR and enzyme immunoassay.

S. KABIR (2001)
J. Med. Microbiol. 50, 1021-1029
 |  Abstract »  |  Full Text »  |  PDF »

Genetic Heterogeneity in Saliva from Patients with Oral Squamous Carcinomas: Implications in Molecular Diagnosis and Screening.

A. K. El-Naggar, L. Mao, G. Staerkel, M. M. Coombes, S. L. Tucker, M. A. Luna, G. L. Clayman, S. Lippman, and H. Goepfert (2001)
J. Mol. Diagn. 3, 164-170
 |  Abstract »  |  Full Text »  |  PDF »

Detection of N-Ras codon 61 mutations in subpopulations of tumor cells in multiple myeloma at presentation.

N. Kalakonda, D. G. Rothwell, J. H. Scarffe, and J. D. Norton (2001)
Blood 98, 1555-1560
 |  Abstract »  |  Full Text »  |  PDF »

Stool DNA-Based Colorectal Cancer Detection: Finding the Needle in the Haystack.

W. Atkin and J. P. Martin (2001)
J Natl Cancer Inst 93, 798-799
 |  Full Text »  |  PDF »

Detecting Colorectal Cancer in Stool With the Use of Multiple Genetic Targets.

S. M. Dong, G. Traverso, C. Johnson, L. Geng, R. Favis, K. Boynton, K. Hibi, S. N. Goodman, M. D'Allessio, P. Paty, et al. (2001)
J Natl Cancer Inst 93, 858-865
 |  Abstract »  |  Full Text »  |  PDF »

Biomarkers for Early Detection of Colon Cancer.

S. Srivastava, M. Verma, and D. E. Henson (2001)
Clin. Cancer Res. 7, 1118-1126
 |  Abstract »  |  Full Text »

Inverse Relationship between Microsatellite Instability and K-ras and p53 Gene Alterations in Colon Cancer.

W. S. Samowitz, J. A. Holden, K. Curtin, S. L. Edwards, A. R. Walker, H. A. Lin, M. A. Robertson, M. F. Nichols, K. M. Gruenthal, B. J. Lynch, et al. (2001)
Am. J. Pathol. 158, 1517-1524
 |  Abstract »  |  Full Text »  |  PDF »

Multiple Detection of Genetic Alterations in Tumors and Stool.

C. Rengucci, P. Maiolo, L. Saragoni, W. Zoli, D. Amadori, and D. Calistri (2001)
Clin. Cancer Res. 7, 590-593
 |  Abstract »  |  Full Text »

K-ras Mutation Detection by Hybridization to a Polypyrrole DNA Chip.

E. Lopez-Crapez, T. Livache, J. Marchand, and J. Grenier (2001)
Clin. Chem. 47, 186-194
 |  Abstract »  |  Full Text »  |  PDF »

Associations between Dietary Intake and Ki-ras Mutations in Colon Tumors: A Population-based Study.

M. L. Slattery, K. Curtin, K. Anderson, K.-N. Ma, S. Edwards, M. Leppert, J. Potter, D. Schaffer, and W. S. Samowitz (2000)
Cancer Res. 60, 6935-6941
 |  Abstract »  |  Full Text »

Associations Between Cigarette Smoking, Lifestyle Factors, and Microsatellite Instability in Colon Tumors.

M. L. Slattery, K. Curtin, K. Anderson, K.-N. Ma, L. Ballard, S. Edwards, D. Schaffer, J. Potter, M. Leppert, and W. S. Samowitz (2000)
J Natl Cancer Inst 92, 1831-1836
 |  Abstract »  |  Full Text »  |  PDF »

Relationship of Ki-ras Mutations in Colon Cancers to Tumor Location, Stage, and Survival: A Population-based Study.

W. S. Samowitz, K. Curtin, D. Schaffer, M. Robertson, M. Leppert, and M. L. Slattery (2000)
Cancer Epidemiol. Biomarkers Prev. 9, 1193-1197
 |  Abstract »  |  Full Text »

Lung Cancer Detection in the 21st Century: Potential Contributions and Challenges of Emerging Technologies.

P. M. Boiselle, A. Ernst, and D. D. Karp (2000)
Am. J. Roentgenol. 175, 1215-1221
 |  Full Text »  |  PDF »

Identifying Potential Tumor Markers and Antigens by Database Mining and Rapid Expression Screening.

W. T. Loging, A. Lal, I-M. Siu, T. L. Loney, C. J. Wikstrand, M. A. Marra, C. Prange, D. D. Bigner, R. L. Strausberg, and G. J. Riggins (2000)
Genome Res. 10, 1393-1402
 |  Abstract »  |  Full Text »

Progression Model for Pancreatic Cancer.

R. H. Hruban, M. Goggins, J. Parsons, and S. E. Kern (2000)
Clin. Cancer Res. 6, 2969-2972
 |  Full Text »

Detection of MUC1-expressing Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients by Real-Time Polymerase Chain Reaction.

P. de Cremoux, J. M. Extra, M. G. Denis, J. Y. Pierga, E. Bourstyn, C. Nos, K. B. Clough, E. Boudou, E. C. Martin, A. Müller, et al. (2000)
Clin. Cancer Res. 6, 3117-3122
 |  Abstract »  |  Full Text »

Molecular stool screening for colorectal cancer.

D. A Ahlquist (2000)
BMJ 321, 254-255
 |  Full Text »

Detection by Denaturant Gradient Gel Electrophoresis of Tumor-specific Mutations in Biopsies and Relative Bronchoalveolar Lavage Fluid from Resectable Non-Small Cell Lung Cancer.

G. Ferretti, G. Curigliano, U. Pastorino, A. Cittadini, G. Flamini, M. G. Calabrò, Tommaso De Pas, L. Orlando, M. Mandalà, M. Colleoni, et al. (2000)
Clin. Cancer Res. 6, 2393-2400
 |  Abstract »  |  Full Text »

Detection of Rare Mutant Alleles by Restriction Endonuclease-mediated Selective-PCR: Assay Design and Optimization.

C. J. Fuery, H. L. Impey, N. J. Roberts, T. L. Applegate, R. L. Ward, N. J. Hawkins, C. A. Sheehan, R. O'Grady, and A. V. Todd (2000)
Clin. Chem. 46, 620-624
 |  Abstract »  |  Full Text »  |  PDF »

Real-Time Quantification of Human Telomerase Reverse Transcriptase mRNA in Tumors and Healthy Tissues.

J. B. de Kok, T. J.M. Ruers, G. N.P. van Muijen, A. van Bokhoven, H. L. Willems, and D. W. Swinkels (2000)
Clin. Chem. 46, 313-318
 |  Abstract »  |  Full Text »  |  PDF »

Microsatellite Alterations in Plasma DNA of Primary Breast Cancer Patients.

J. A. Shaw, B. M. Smith, T. Walsh, S. Johnson, L. Primrose, M. J. Slade, R. A. Walker, and R. C. Coombes (2000)
Clin. Cancer Res. 6, 1119-1124
 |  Abstract »  |  Full Text »

Molecular Detection of Neoplastic Cells in Lymph Nodes of Metastatic Colorectal Cancer Patients Predicts Recurrence.

M. Sanchez-Cespedes, M. Esteller, K. Hibi, F. O. Cope, W. H. Westra, S. Piantadosi, J. G. Herman, J. Jen, and D. Sidransky (1999)
Clin. Cancer Res. 5, 2450-2454
 |  Abstract »  |  Full Text »  |  PDF »

Digital PCR.

B. Vogelstein and K. W. Kinzler (1999)
PNAS 96, 9236-9241
 |  Abstract »  |  Full Text »  |  PDF »

Detection of Helicobacter pylori DNA in Fecal Samples from Infected Individuals.

W. A. Gramley, A. Asghar, H. F. Frierson Jr., and S. M. Powell (1999)
J. Clin. Microbiol. 37, 2236-2240
 |  Abstract »  |  Full Text »

Presence of Tumor DNA in Plasma of Breast Cancer Patients: Clinicopathological Correlations.

J. M. Silva, G. Dominguez, J. M. Garcia, R. Gonzalez, M. J. Villanueva, F. Navarro, M. Provencio, S. San Martin, P. Espana, and F. Bonilla (1999)
Cancer Res. 59, 3251-3256
 |  Abstract »  |  Full Text »  |  PDF »

Molecular screening of patients with long standing extensive ulcerative colitis: detection of p53 and Ki-ras mutations by single strand conformation polymorphism analysis and differential hybridisation in colonic lavage fluid.

S M Lang, D F Stratakis, M Heinzlmann, W Heldwein, B Wiebecke, and K Loeschke (1999)
Gut 44, 822-825
 |  Abstract »  |  Full Text »  |  PDF »

Detection of K-ras Mutations of Bronchoalveolar Lavage Fluid Cells Aids the Diagnosis of Lung Cancer in Small Pulmonary Lesions.

F. Oshita, I. Nomura, K. Yamada, Y. Kato, G. Tanaka, and K. Noda (1999)
Clin. Cancer Res. 5, 617-620
 |  Abstract »  |  Full Text »  |  PDF »

Molecular Detection of Tumor Cells in Bronchoalveolar Lavage Fluid From Patients With Early Stage Lung Cancer.

S. A. Ahrendt, J. T. Chow, L.-H. Xu, S. C. Yang, C. F. Eisenberger, M. Esteller, J. G. Herman, L. Wu, P. A. Decker, J. Jen, et al. (1999)
J Natl Cancer Inst 91, 332-339
 |  Abstract »  |  Full Text »  |  PDF »

K-ras mutations in stools and tissue samples from patients with malignant and nonmalignant pancreatic diseases.

C. Berndt, K. Haubold, F. Wenger, B. Brux, J. Muller, P. Bendzko, T. Hillebrand, E. Kottgen, and J. Zanow (1998)
Clin. Chem. 44, 2103-2107
 |  Abstract »  |  Full Text »  |  PDF »

Restriction Endonuclease-Mediated Selective Polymerase Chain Reaction : A Novel Assay for the Detection of K-ras Mutations in Clinical Samples.

R. Ward, N. Hawkins, R. O'Grady, C. Sheehan, T. O'Connor, H. Impey, N. Roberts, C. Fuery, and A. Todd (1998)
Am. J. Pathol. 153, 373-379
 |  Abstract »  |  Full Text »  |  PDF »

Rapid sequencing of the p53 gene with a new automated DNA sequencer.

B. S. Bharaj, K. Angelopoulou, and E. P. Diamandis (1998)
Clin. Chem. 44, 1397-1403
 |  Abstract »  |  Full Text »  |  PDF »

Science, medicine, and the future: Molecular assessment of cancer.

C. Caldas (1998)
BMJ 316, 1360-1363
 |  Full Text »

Rearranged Ig Heavy Chain DNA Is Detectable in Cell-Free Blood Samples of Patients With B-Cell Neoplasia.

N. Frickhofen, E. Muller, M. Sandherr, T. Binder, M. Bangerter, C. Wiest, M. Enz, and H. Heimpel (1997)
Blood 90, 4953-4960
 |  Abstract »  |  Full Text »  |  PDF »

Methods for detection of point mutations: performance and quality assessment.

P. Nollau and C. Wagener (1997)
Clin. Chem. 43, 1114-1128
 |  Abstract »  |  Full Text »  |  PDF »

Screening for Colorectal Cancer: A Comparison of 3 Fecal Occult Blood Tests.

B. Levin, K. Hess, and C. Johnson (1997)
Arch Intern Med 157, 970-976
 |  Abstract »  |  PDF »

Fortnightly review: screening for asymptomatic colorectal cancer.

H. E Mulcahy, M. J G Farthing, and D. P O'Donoghue (1997)
BMJ 314, 285
 |  Full Text »

Prevention of Colorectal Cancer by Endoscopic Polypectomy.

J. Van Dam (1995)
Ann Intern Med 123, 949-950
 |  Full Text »

Activated ras Genes Occur in Human Actinic Keratoses, Premalignant Precursors to Squamous Cell Carcinomas.

J. M. Spencer, S. M. Kahn, W. Jiang, V. A. DeLeo, and I. B. Weinstein (1995)
Arch Dermatol 131, 796-800
 |  Abstract »  |  PDF »

Cost of Patient Follow-up After Potentially Curative Colorectal Cancer Treatment.

K. S Virgo, A. M. Vernava, W. E. Longo, L. W. McKirgan, and F. E. Johnson (1995)
JAMA 273, 1837-1841
 |  Abstract »  |  PDF »

Screening for Colorectal Cancer.

N. W. Toribara and M. H. Sleisenger (1995)
N. Engl. J. Med. 332, 861-867
 |  Full Text »  |  PDF »

Molecular Assessment of Histopathological Staging in Squamous-Cell Carcinoma of the Head and Neck.

J. A. Brennan, L. Mao, R. H. Hruban, J. O. Boyle, Y. J. Eby, W. M. Koch, S. N. Goodman, and D. Sidransky (1995)
N. Engl. J. Med. 332, 429-435
 |  Abstract »  |  Full Text »  |  PDF »

Cell cycle control and cancer.

L. Hartwell and M. Kastan (1994)
Science 266, 1821-1828
 |  Abstract »  |  PDF »

p53 Gene Mutations as Markers of Tumor Spread in Synchronous Oral Cancers.

W. M. Koch, J. O. Boyle, L. Mao, J. Hakim, R. H. Hruban, and D. Sidransky (1994)
Arch Otolaryngol Head Neck Surg 120, 943-947
 |  Abstract »  |  PDF »

Allelic Loss of Chromosome 18q and Prognosis in Colorectal Cancer.

J. Jen, H. Kim, S. Piantadosi, Z.-F. Liu, R. C. Levitt, P. Sistonen, K. W. Kinzler, B. Vogelstein, and S. R. Hamilton (1994)
N. Engl. J. Med. 331, 213-221
 |  Abstract »  |  Full Text »

Molecular Biology and the Early Detection of Carcinoma of the Bladder -- The Case of Hubert H. Humphrey.

R. H. Hruban, P. van der Riet, Y. S. Erozan, and D. Sidransky (1994)
N. Engl. J. Med. 330, 1276-1278
 |  Full Text »

Poster Session.

(1993)
Toxicol Pathol 21, 623-646
 |  PDF »

Molecular Screening: Prospects for a New Approach.

D. Sidransky, J. Boyle, and W. Koch (1993)
Arch Otolaryngol Head Neck Surg 119, 1187-1190
 |  Abstract »  |  PDF »

Clinical Implications of the p53 Tumor-Suppressor Gene.

C. C. Harris and M. Hollstein (1993)
N. Engl. J. Med. 329, 1318-1327
 |  Full Text »

Gastroenterology.

D. F. Ransohoff (1993)
JAMA 270, 206-209
 |  Abstract »  |  PDF »

Pathology and Laboratory Medicine.

C. M. Fenoglio-Preiser and A. J. Pesce (1993)
JAMA 270, 245-246
 |  Abstract »  |  PDF »

Animal Models for Colon Carcinogenesis.

S. E. Pories, N. Ramchurren, I. Summerhayes, and G. Steele (1993)
Arch Surg 128, 647-653
 |  Abstract »  |  PDF »

Clues to the pathogenesis of familial colorectal cancer.

L. Aaltonen, P Peltomaki, F. Leach, P Sistonen, L Pylkkanen, J. Mecklin, H Jarvinen, S. Powell, J Jen, Hamilton SR, et al. (1993)
Science 260, 812-816
 |  Abstract »  |  PDF »

Screening for Cancers of the Lung and Colon.

K. E. Richert-Boe and L. L. Humphrey (1992)
Arch Intern Med 152, 2398-2404
 |  Abstract »  |  PDF »

ONCOGENE DETECTED IN STOOL OF PATIENTS WITH CURABLE COLON CANCER.

(1992)
Journal Watch (General) 1992, 1
 |  Full Text »

To Advertise   |   Find Products